Physostigmine SalicylateThird Party Manufacturing in India

Physostigmine Salicylate works by reversibly binding to and inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine at cholinergic junctions. This inhibition raises acetylcholine concentrations at post-synaptic receptors, reversing anticholinergic blocks. Unlike quaternary ammonium compounds, its tertiary amine structure allows it to easily cross the blood-brain barrier, effectively reversing both central and peripheral anticholinergic toxicity. It is highly effective and well-tolerated when monitored closely.

Therapeutic Uses

• Anticholinergic Toxicity: Reverses central nervous system toxicity caused by overdosage of atropine, antihistamines, or tricyclic antidepressants.
• Post-Anesthetic Shivering: Restores normal central thermoregulation following certain general anesthetic procedures.

Why Manufacturers Choose Physostigmine Salicylate

Partnering for Physostigmine Salicylate third party manufacturing in India allows companies to provide a specialized emergency antidote for hospital networks. Celesta Healthcare satisfies this critical care niche by ensuring our partner facilities are WHO-GMP certified and maintain strict control over pH stabilization and oxygen exposure during filling. This keeps the active compound under CAS number 57-64-7 chemically stable. Manufacturing under strict WHO-GMP rules ensures high purity and reliable performance, helping your brand win specialized hospital contracts and emergency supply agreements.